Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹539Cr
Rev Gr TTM
Revenue Growth TTM
10,533.33%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MSCTC
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | | | | | | -100.0 | | |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 10 |
Operating Profit Operating ProfitCr |
| | | | | | -141.7 | | | | | 4.9 | 15.4 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 2 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
|
Growth YoY PAT Growth YoY% | -113.3 | 94.4 | | -1,100.0 | -1,450.0 | -1,700.0 | -3,475.0 | 58.3 | 83.9 | -27.8 | 101.4 | 2,680.0 |
| | | | | | -150.0 | | | | | 4.9 | 10.4 |
| 0.0 | 0.0 | -0.1 | 0.0 | -0.4 | -0.3 | -2.0 | -0.1 | -0.1 | -0.3 | 0.0 | 1.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -94.9 | -100.0 | | | | | | | | | |
| 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 11 |
Operating Profit Operating ProfitCr |
| -1,759.1 | -16,149.0 | | | | | | | | | | 12.8 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 2 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
|
| | 72.5 | -31.5 | -8.0 | 29.8 | 8.6 | 89.8 | 222.6 | -777.8 | -124.3 | 335.3 | -14.1 |
| -2,077.7 | -11,282.5 | | | | | | | | | | 8.1 |
| -1.5 | 0.0 | -0.6 | -0.6 | -0.4 | -0.4 | 0.0 | 0.1 | -0.3 | -0.7 | 1.7 | 1.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| 9 | 9 | 9 | 8 | -2 | -2 | -2 | -2 | -2 | -3 | -1 | -2 |
Current Liabilities Current LiabilitiesCr | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 1 |
Non Current Liabilities Non Current LiabilitiesCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 0 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 12 | 12 | 11 | 11 | 2 | 2 | 2 | 3 | 3 | 1 | 3 | 3 |
Non Current Assets Non Current AssetsCr | 7 | 7 | 7 | 6 | 5 | 5 | 5 | 5 | 5 | 6 | 3 | 3 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -1 | 3 |
Financing Cash Flow Financing Cash FlowCr | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Free Cash Flow Free Cash FlowCr | -6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| 568.9 | 156.1 | 119.3 | 51.8 | 108.2 | -5.5 | -3.7 | 13.3 | 0.3 | 11.8 | -211.3 |
CFO To EBITDA CFO To EBITDA% | 671.9 | 109.1 | 73.8 | 59.0 | 100.6 | -4.5 | -0.4 | -1.1 | 0.2 | 10.5 | 162.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 2 | 2 | 2 | 0 | 1 | 0 | 0 | 0 | 6 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.3 |
Price To Sales Price To Sales | 0.0 | | | | | | | | | | |
Price To Book Price To Book | 0.0 | 0.0 | 0.2 | 0.2 | 1.3 | 0.0 | 1.5 | 0.0 | 0.0 | 0.0 | 4.7 |
| -0.2 | 0.6 | -2.9 | -3.5 | -3.0 | 1.8 | -2.9 | 1.5 | 1.3 | -1.4 | -4.1 |
Profitability Ratios Profitability Ratios |
| -99.3 | 100.0 | | | | | | | | | |
| -1,759.1 | -16,149.0 | | | | | | | | | |
| -2,077.7 | -11,282.5 | | | | | | | | | |
| -6.5 | -2.0 | -2.5 | -2.9 | -5.4 | -5.2 | -0.5 | 0.7 | -4.6 | -9.7 | 21.3 |
| -6.6 | -1.9 | -2.5 | -2.9 | -5.4 | -5.2 | -0.5 | 0.7 | -4.6 | -11.5 | 21.3 |
| -5.6 | -1.5 | -2.2 | -2.5 | -3.8 | -3.5 | -0.3 | 0.4 | -2.9 | -7.5 | 20.9 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
This comprehensive investor profile analyzes **Mardia Samyoung Capillary Tubes Company Limited**, an Indo-Korean Joint Venture currently undergoing a radical structural transformation. Following a change in management in late 2024 and early 2025, the company is transitioning from a legacy manufacturer of industrial metal components into a diversified entity with interests in precious metals, e-commerce, and agriculture.
---
### I. Corporate Identity and Strategic Pivot
Mardia Samyoung Capillary Tubes Company Limited was originally established to manufacture high-precision non-ferrous metal products. In **June 2025**, the company underwent a definitive change in control. **Torextron Ventures Private Limited** acquired a **69.41%** stake in the company at a negotiated price of **₹5.00 per share**, triggering a mandatory open offer and a complete overhaul of the Board of Directors.
Under new leadership, the company has pivoted from a "Sick Company" status toward a diversified business model. While it retains its industrial roots, it has expanded its constitutional objects to include high-margin sectors such as gems, jewelry, and digital commerce.
---
### II. Diversified Business Verticals and Product Portfolio
The company’s operational framework is now divided into two primary segments, supported by a newly authorized mandate for trading and services.
#### **1. Industrial Metal Components (Legacy Core)**
The company maintains the technical capacity to manufacture and trade copper and brass alloy products, primarily serving the HVAC (Heating, Ventilation, and Air Conditioning) and refrigeration sectors.
* **Copper Tubing:** Straight and coiled tubes compliant with **ASTM B819** and **ASME SB280** standards.
* **Precision Parts:** Pre-cut/bent tubes, solder/braze fittings, distributors, and accumulators.
* **Brass Hardware:** Ball valves, gate valves, check valves, bushings, and nipples.
* **Custom Engineering:** Manufacturing of busbars, sections, and profiles based on client technical specifications.
#### **2. Gems, Jewelry, and Luxury Goods (New Growth Engine)**
In **October 2025**, the company expanded its objects to include the processing and retailing of precious materials:
* **Gemstones:** Natural and man-made stones including **Diamonds (Industrial, Cut, and Uncut)**, Rubies, Pearls, Sapphires, Emeralds, and semi-precious stones like Amethyst and Jade.
* **Jewelry:** Manufacturing and hallmarking of ornaments made of **Gold, Silver, and Platinum**.
* **Luxury Accessories:** Trading and distribution of watches, sunglasses, and umbrellas.
#### **3. Digital Commerce and Services**
The company is authorized to develop **online shopping platforms and virtual malls**. Additionally, it acts as a **C&F agent, broker, and valuer**, providing services such as electroplating, gemstone polishing, and manpower consultancy.
---
### III. Operational Infrastructure and Geographic Footprint
The company’s administrative and manufacturing nodes are concentrated in the industrial corridors of Western India:
| Facility Type | Location |
| :--- | :--- |
| **Manufacturing Plant** | J-55/56, **M.I.D.C. Industrial Estate**, Tarapur, Boisar, Maharashtra |
| **Registered Office** | A-108, 1st Floor, Chikuwadi, WE Highway, **Andheri East, Mumbai** |
| **Corporate Office** | Shop-511, Pratik Mall, Kudasan, **Gandhinagar, Gujarat** |
*Note: While a move to Gujarat was proposed in August 2025, the Board resolved in October 2025 to retain the Mumbai headquarters to leverage superior commercial prospects.*
---
### IV. Capital Restructuring and Fundraising
To fund its new business objects and address working capital needs, the company has executed a massive expansion of its capital base.
* **Authorized Capital Expansion:** Increased from **₹29.45 Crore** to **₹80.00 Crore** in **October 2025**.
* **Preferential Warrant Issue:** The Board approved the issuance of **7,25,00,000 Fully Convertible Equity Warrants** at **₹13.50** per warrant (including a **₹3.50 premium**), targeting a total raise of approximately **₹97.87 Crore**.
**Warrant Allotment Summary (February 2026):**
| Tranche | Allottee Category | Warrants Allotted |
| :--- | :--- | :--- |
| **Tranche 1** | Non-Promoter (3 Individuals) | **1,17,00,000** |
| **Tranche 2** | **Promoter (Torextron Ventures)** | **1,30,90,200** |
| **Tranche 3** | Non-Promoter (7 Individuals) | **2,42,29,800** |
| **Tranche 4** | Non-Promoter (6 Individuals) | **2,34,80,000** |
| **Total** | | **7,25,00,000** |
*Terms: Allottees paid **25%** of the issue price upfront, with the remaining **75%** due upon conversion within **18 months**.*
---
### V. Financial Performance and Asset Status
The company is currently in a "pre-revenue" phase following its restructuring, reporting **Nil Revenue from Operations** for **FY 2023-24** and **FY 2024-25**.
| Financial Metric (INR) | FY 2024-25 | FY 2023-24 |
| :--- | :--- | :--- |
| **EBITDA** | **27,632,807** | **(4,819,206)** |
| **Profit After Tax (PAT)** | **11,994,609** | **(5,098,494)** |
| **Net Worth** | **56,319,563** | **44,324,954** |
| **Paid-up Capital (Historical)** | **69,614,100** | **69,614,100** |
**Asset Profile Note:** As of **June 2025**, the company disclosed it **does not own any immovable property**, having liquidated its land, buildings, and machinery during the **2024-25** fiscal year to address legacy issues.
---
### VI. Risk Factors and Regulatory Challenges
Investors should note that the company is emerging from a period of significant distress and faces several high-impact risks.
#### **1. Operational and Asset Risks**
* **Total Shutdown:** The company previously ceased all operations and wrote off its entire inventory (**₹74.28 Lakhs**) due to obsolescence.
* **Verification Gaps:** As of **November 2025**, balances for Trade Receivables, Payables, and Loans remain pending external reconciliation.
#### **2. Regulatory Non-Compliance**
The company has historically struggled with SEBI and MCA compliance:
* **LODR Violations:** Non-compliance with Regulations **7(3), 13, 23(9), 33, and 38**.
* **Insider Trading:** Failure to maintain a **Structured Digital Database (SDD)** and lapses in **Trading Window Closures** during 2024.
* **Audit Qualifications:** The statutory auditor lacked a valid **Peer Reviewed Certificate**, a mandatory requirement for listed companies.
#### **3. Contingent Liabilities and Tax Disputes**
The company is encumbered by substantial legacy claims:
* **Customs & Excise:** Estimated liabilities of **₹748.52 Lacs** (Customs) and **₹655.01 Lacs** (Excise) related to unfulfilled export obligations (EPCG).
* **Bank Guarantees:** Outstanding guarantees totaling **₹129.84 Lacs**.
#### **4. Shareholding Compliance**
The company must maintain a **Minimum Public Shareholding (MPS) of 25%**. If the conversion of the **7.25 Crore warrants** causes the promoter stake to exceed **75%**, the Acquirer is legally obligated to dilute their holding within **12 months**.